Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ROCKWELL MEDICAL, INC.RMTI · Entity 7426 | Vice President, CFO | December 15, 2017 | December 19, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ROCKWELL MEDICAL, INC.
Report date December 15, 2017 · Filed December 19, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 671,492 |
Ending reported balance
After 2017-12-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-12-15 · Exercise / conversion · Acquired 87,500 · Balance 757,667 Row 2 · 2017-12-15 · Tax withholding · Disposed 86,175 · Balance 671,492 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.50 · Expires 2017-12-17 | Direct | 0 |
Reported balance
After 2017-12-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-12-15 · Exercise / conversion · Disposed 87,500 · Balance 0 F1: The option became exercisable in three equal installments on December 17, 2008, December 17, 2009, and December 17, 2010. F2: Since the date of the reporting person's last ownership report with respect to this option, he transferred 87,500 of the 175,000 options granted on 12/17/2007 directly to his former spouse to satisfy a portion of his obligations pursuant to a qualified domestic relations order. |
Filing footnotes · ownership attribution and instrument terms
F1: The option became exercisable in three equal installments on December 17, 2008, December 17, 2009, and December 17, 2010.
F2: Since the date of the reporting person's last ownership report with respect to this option, he transferred 87,500 of the 175,000 options granted on 12/17/2007 directly to his former spouse to satisfy a portion of his obligations pursuant to a qualified domestic relations order.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2017 Filed Dec 19, 2017 22:51 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Exercise / conversionStock Option (Right to Buy) · Derivative | 87,500 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001209191-17-066451 · doc4.xml · derivative · entry 3 KLEMA THOMAS E · CIK 0001215042 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,500 shares Expires 2017-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in three equal installments on December 17, 2008, December 17, 2009, and December 17, 2010. F2 · balance_after: Since the date of the reporting person's last ownership report with respect to this option, he transferred 87,500 of the 175,000 options granted on 12/17/2007 directly to his former spouse to satisfy a portion of his obligations pursuant to a qualified domestic relations order. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 22:51 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Tax withholdingCommon Stock | 86,175 | $6.60 | $568,755.00 |
DisclosureSEC source: 0001209191-17-066451 · doc4.xml · nonDerivative · entry 2 KLEMA THOMAS E · CIK 0001215042 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 671,492 Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 22:51 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Exercise / conversionCommon Stock | 87,500 | $6.50 | $568,750.00 |
DisclosureSEC source: 0001209191-17-066451 · doc4.xml · nonDerivative · entry 1 KLEMA THOMAS E · CIK 0001215042 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:55 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Tax withholdingCommon Stock | 53,273 | $7.20 | $383,565.60 |
DisclosureSEC source: 0001209191-17-041691 · doc4.xml · nonDerivative · entry 1 KLEMA THOMAS E · CIK 0001215042 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 670,167 F1 · shares: Shares surrendered to Company in order to satisfy withholding tax obligations. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 22:38 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 68,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-022659 · doc4.xml · nonDerivative · entry 1 KLEMA THOMAS E · CIK 0001215042 · Vice President, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 723,440 F1 · shares: Performance-based stock grant. This grant vests upon the earliest to occur of any of the following (a) reported net sales of the company in any four consecutive calendar quarters equals or exceeds $100,000,000, (b) the market capitalization of the company is greater than $600,000,000 for ten consecutive trading days, or (c) one year following the date the Centers for Medicare & Medicaid Services assign the company transitional add on reimbursement payment status for the drug product, Triferic. F2 · balance_after: Since the date of the reporting person's last ownership report, he has transferred 22,400 shares of common stock to his ex-wife pursuant to a domestic relations order. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.